Global Test Strip Market: Executive Summary Global Test Strip Market: Research Methodology Table of content for the Test Strip Market includes: EKF Diagnostics Holdings plc (Cardiff, United Kingdom.).TaiDoc Technology Corporation (Taipei, Taiwan).AgaMatrix Holdings LLC (New Hampshire, USA.).Nova Biomedical Corporation (Waltham, Massachusetts, USA).Ascensia Diabetes Care (Basel, Switzerland).Johnson & Johnson (New Brunswick, New Jersey).Becton, Dickinson and Company (BD) (New Jersey, USA).Siemens Healthcare GmbH (Erlangen, Germany).Efforts by national governments to manage these diseases further contribute to the region's growth. North America leads the Test Strip Market, driven by the increasing cases of diabetes and urinary tract infections. What is Test Strip Market Regional Insight? Technological Advancements: Ongoing innovation and product advancements in the test strip market are contributing to industry growth. As per the National Diabetes Statistics report, the incidence of diabetes is on the rise, driving the demand for blood glucose test strips.ĭemand for Convenient Diagnostic Solutions: The growing demand for easy-to-use diagnostic solutions for monitoring blood glucose levels and urinalysis is fueling the Test Strip Market's growth. Rising Prevalence of Diabetes: The global Test Strip Market is experiencing significant growth due to the increasing prevalence of diabetes worldwide. The ease of use and convenience offered by test strips make them a popular choice for patients and healthcare providers alike. Additionally, urinalysis test strips are vital for monitoring kidney function and detecting urinary tract infections. These strips are essential for monitoring and controlling glucose levels in diabetic patients, enabling them to manage their condition effectively. Test strips play a crucial role in the field of medical diagnostics, particularly in blood glucose testing and urinalysis. Request a Free Sample Copy or View Report Summary: Major players are investing in research and development to develop innovative and cost-effective products, such as the non-invasive Contour Next One blood glucose meter developed by Ascensia Diabetes Care in collaboration with 9am.health. Very accurate: thanks to Multi-Pulse technology, every drop of blood is tested 7 times.The competitive landscape is characterized by market expansion, acquisitions, and partnerships.Not to be used on the Contour & Contour TS meter. Only suitable for the Contour USB Next, Contour Next One, Contour XT, Contour Next Link & Contour Next Link 2.4. We are proud to be your partner in managing your diabetes. Thank you for choosing Bayers CONTOUR NEXT blood glucose meter. Avoid getting blood directly on the flat part of the test strip. Your test strip is designed to easily absorb blood into the sample tip. It automatically marks a control solution test.Įnough blood: The CONTOUR NEXT meter warns you if a test strip is too low in blood and allows you to add more blood. multi-pulse technology from Asensia where the blood is absorbed and measured up to 7x.Īutomatic: Bayer's CONTOUR NEXT meter is designed with No Coding technology to automatically code itself every time you insert a test strip. This is also expressed in the advantageous testing by means of. You will notice this immediately the first time you use the meter. The most important thing about the CONTOUR NEXT blood glucose system is its simplicity. The Contour Next test strips from Ascensia formerly Bayer Next blood glucose test strips.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |